We are excited to announce that Gelomics is now a supplier on Scientist.com! Through this leading platform for scientific sourcing, we are providing simple, fast and reliable access to our innovative 3D tissue culture products and services in the US. Why choose Gelomics on Scientist.com? Since 2007, Scientist.com has become a trusted supplier for the […]
Gelomics proudly announces a strategic partnership with Voden Medical. Voden Medical is a renowned provider of advanced diagnostic and life science solutions in Italy. Under this agreement, Voden Medical will serve as Gelomics’ exclusive distributor in the Italian market. This partnership, effective January 2025, marks a significant step forward in Gelomics’ mission to bring our […]
Gelomics is pleased to announce a new strategic partnership with Bucher Biotec AG, a leading provider of advanced life science solutions in Switzerland & Lichtenstein. Under this agreement, Bucher Biotec will serve as Gelomics’ exclusive distributor across the Swiss market. This partnership marks an important milestone for Gelomics as we expand our presence in Europe. […]
Gelomics, a leading Australian biotech firm at the forefront of drug development innovation, is further strengthening its Scientific Advisory Board with the addition of Distinguished Professor Dietmar W. Hutmacher, PhD, MBA, and Professor Travis J. Klein, PhD. Following the recent appointment of Professor Dame Molly Stevens, FREng FRS, these new appointments reinforce our commitment to […]
We’re thrilled to unveil our latest innovation! LunaGel™ Ultrapure GelMA Photocrosslinkable Extracellular Matrix (ECM), now available in both High Stiffness and Low Stiffness options. Developed in collaboration with Rousselot Biomedical, this breakthrough leverages the advanced X-Pure® GelMA technology, setting a new standard for 3D cell culture by offering unparalleled control over matrix porosity and stiffness. […]
+61 1800 865 060
Send us an email here
60 Musk Avenue
Kelvin Grove, QLD 4059
Australia
ABN 14 624 623 623
